Nova Patents
IL211762D0

Pegylated opioids with low potential for abuse

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

97 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims9

Priority claims
DocumentOfficeKindDate
19224708United States of AmericaP
55839509United States of AmericaA
2009005174United States of AmericaW
12558395–––
61192247–––
PCTUS2009005174–––
US20080192247P–––
US20090558395–––
WO2009US05174–––

Members97

Family members, oldest first
DocumentOfficeKind
AU2008226822A1AustraliaA1
CA2679479A1CanadaA1
WO2008112288A2World Intellectual Property Organization (WIPO)A2
WO2008112288A3World Intellectual Property Organization (WIPO)A3
MX2009009851AMexicoA
KR20090118952ARepublic of KoreaA
EP2134371A2European Patent Office (EPO)A2
CN101646464AChinaA
US2010048602A1United States of AmericaA1
AU2009292631A1AustraliaA1
CA2734333A1CanadaA1
WO2010033195A1World Intellectual Property Organization (WIPO)A1
IL200845A0IsraelA0
JP2010521466AJapanA
CA2768392A1CanadaA1
WO2011011543A1World Intellectual Property Organization (WIPO)A1
MX2011002748AMexicoA
KR20110058783ARepublic of KoreaA
IL211762A0IsraelA0
IL211762D0This recordIsraelD0
EP2340044A1European Patent Office (EPO)A1
CN102159249AChinaA
US2011237614A1United States of AmericaA1
JP2012502904AJapanA
AU2010276244A1AustraliaA1
US8173666B2United States of AmericaB2
EP2456469A1European Patent Office (EPO)A1
KR20120056828ARepublic of KoreaA
CN102573918AChinaA
US2012184581A1United States of AmericaA1
US2012264775A1United States of AmericaA1
US2012289548A1United States of AmericaA1
JP2013500256AJapanA
US8440687B2United States of AmericaB2
CN101646464BChinaB
EP2620163A1European Patent Office (EPO)A1
AU2008226822B2AustraliaB2
EP2623123A1European Patent Office (EPO)A1
JP2013151563AJapanA
EP2628489A1European Patent Office (EPO)A1
US8569343B2United States of AmericaB2
US8575196B2United States of AmericaB2
JP5420427B2JapanB2
US2014187790A1United States of AmericaA1
US2014200235A1United States of AmericaA1
EP2134371B1European Patent Office (EPO)B1
US8946285B2United States of AmericaB2
US8952032B2United States of AmericaB2
PT2134371EPortugalE
US2015112069A1United States of AmericaA1
HRP20150315T1CroatiaT1
DK2134371T3DenmarkT3
ES2534741T3SpainT3
SI2134371T1SloveniaT1
PL2134371T3PolandT3
AU2010276244B2AustraliaB2
US2015238624A1United States of AmericaA1
IL200845AIsraelA
RS53937B1SerbiaB1
CA2679479CCanadaC
JP2015180698AJapanA
KR101568428B1Republic of KoreaB1
JP5827123B2JapanB2
JP5837491B2JapanB2
US9233167B2United States of AmericaB2
US9233168B2United States of AmericaB2
JP5877403B2JapanB2
CN105503889AChinaA
US2016130276A1United States of AmericaA1
IL211762AIsraelA
US2016214990A1United States of AmericaA1
US2016243111A1United States of AmericaA1
KR101660996B1Republic of KoreaB1
US9458166B2United States of AmericaB2
US9512135B2United States of AmericaB2
US2016375009A1United States of AmericaA1
EP2628489B1European Patent Office (EPO)B1
US2017112826A1United States of AmericaA1
EP2620163B1European Patent Office (EPO)B1
MX347741BMexicoB
EP3222293A1European Patent Office (EPO)A1
KR101788886B1Republic of KoreaB1
US9827239B2United States of AmericaB2
IL217634AIsraelA
CA2768392CCanadaC
EP3342427A1European Patent Office (EPO)A1
US2018256563A1United States of AmericaA1
US10143690B2United States of AmericaB2
IL256822AIsraelA
IL263713AIsraelA
US2019046523A1United States of AmericaA1
US10307416B2United States of AmericaB2
US2019247388A1United States of AmericaA1
EP3222293B1European Patent Office (EPO)B1
CN105503889BChinaB
US10512644B2United States of AmericaB2
US2020078353A1United States of AmericaA1